(15055031), A. E., (15055034), L. S., (15055037), S. I. V., (15055040), L. A. H., (14947288), C. A. L., (15055043), V. F., . . . (14947294), C. L. (2025). Supplementary Table S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.
Citace podle Chicago (17th ed.)(15055031), Andrés Elía, et al. Supplementary Table S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. 2025.
Citace podle MLA (9th ed.)(15055031), Andrés Elía, et al. Supplementary Table S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. 2025.